<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of agents including the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter 12-0-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>-<z:chebi fb="0" ids="45127">phorbol-13-acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) can induce an abortive virus cycle in the EBV-non-producer Burkitt's-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> line Raji </plain></SENT>
<SENT sid="1" pm="."><plain>Two distant regions, DL and DR, of the EBV genome with almost complete homology carry strong promoters which are induced in an abortive or lytic cycle and additionally function as lytic origins of <z:mp ids='MP_0001799'>viral</z:mp> DNA replication </plain></SENT>
<SENT sid="2" pm="."><plain>To set up a system in which the activity of EBV-inducing agents can be measured in a quantitative and reproducible fashion, we generated a cell line which carries multiple copies of a DR-promoter <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi>-acetyltransferase (CAT) construct on an episomal vector </plain></SENT>
<SENT sid="3" pm="."><plain>CAT activity is low in untreated cells, but high upon treatment of the cells with various EBV-inducing agents </plain></SENT>
<SENT sid="4" pm="."><plain>Combinations of different agents can produce an over-additive effect </plain></SENT>
<SENT sid="5" pm="."><plain>The Raji-DR-CAT cell line may provide a simple quantitative and reproducible test system for EBV-inducing agents, especially for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoters which activate protein kinases C </plain></SENT>
</text></document>